Senior Consultant - Data Capability at Eli Lilly and Company

Bengaluru, Karnataka, India

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
NoVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Bachelor’s Degree
  • Ensure compliance with company policies

Responsibilities

  • Collate information regarding the different datasets relevant for SFO
  • Conduct detailed analysis of current data flows and architecture
  • Establish industry best in class data architecture and flows to enable creation of standard data products to be leveraged across analysis and reports
  • Coordinate with multiple teams like DataSpine, Tech to ensure all required datasets are available in the right format and at the right cadence
  • Establish data quality controls to flag any discrepancy in the datasets to source teams (via automated flows)
  • Work with both structured and unstructured data which would be fed into AI / Gen AI based tools and reports
  • Generate and maintain SFO reports database. Draw insights by comparing data across different time stamps
  • Setup, maintain and manage standard SFO LLMs / agents based on both structured and unstructured datasets
  • Create process maps, SOPs and detailed documentation
  • Lead and upskill a team of data enthusiasts to support all field facing roles
  • Lead ideation initiatives to identify and solve cross team problems

Skills

Sales Operations
Data Capabilities
Consulting

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI